Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 10, 2026
REGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA(Euronext Brussels/Nasdaq:…
TransAlta Corporation Announces Results of the 2026 Annual and Special Meeting of Shareholders and Election of all Directors
April 30, 2026 18:45 ET | Source: TransAlta Corporation CALGARY, Alberta, April…
Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
PASADENA, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one…
Nagarro releases audited financial statements and annual report for FY 2025, reaffirms the preliminary numbers
Revenue of €999 million (+2.8%) represents 6.1% constant currency growth;Gross profit of €321 million…
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders Meeting
EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of…
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
April 27, 2026 17:00 ET | Source: Cabaletta Bio PHILADELPHIA, April 27,…
ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: ElevateBio – Posters detail large…
Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: Arbor Biotechnologies Inc - Oral…
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting
April 23, 2026 12:00 ET | Source: Catheter Precision, Inc. VIVO System…
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability…
